Page 54 - Read Online

Akabane et al. Hepatoma Res 2023;9:29 https://dx.doi.org/10.20517/2394-5079.2023.45 Page 9 of 9

48. Zhang H, Yang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management.
Cancer Lett 2016;379:198-205. DOI
49. Smith TJ, Temin S, Alesi ER, et al. American society of clinical oncology provisional clinical opinion: the integration of palliative care
into standard oncology care. J Clin Oncol 2012;30:880-7. DOI
50. Sapisochin G, Rodríguez de Lope C, Gastaca M, et al. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver
transplantation be reconsidered in these patients? Am J Transplant 2014;14:660-7. DOI PubMed
51. Darwish Murad S, Kim WR, Harnois DM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for
perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012;143:88-98.e3; quiz e14. DOI PubMed PMC
52. Heimbach JK, Gores GJ, Haddock MG, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis
2004;24:201-7. DOI
53. Hong JC, Petrowsky H, Kaldas FM, et al. Predictive index for tumor recurrence after liver transplantation for locally advanced
intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg 2011;212:514-20; discussion 520. DOI
54. Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar
cholangiocarcinoma: a 24-year experience in a single center. Arch Surg 2011;146:683-9. DOI
55. Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2016 annual data report: liver. Am J Transplant 2018;18 Suppl 1:172-253. DOI
56. Hue JJ, Rocha FG, Ammori JB, et al. A comparison of surgical resection and liver transplantation in the treatment of intrahepatic
cholangiocarcinoma in the era of modern chemotherapy: an analysis of the national cancer database. J Surg Oncol 2021;123:949-56.
DOI
57. Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living
donations safe. Liver Transpl 2006;12:920-7. DOI
58. Filippi R, Montagnani F, Lombardi P, et al. A prognostic model in patients with advanced biliary tract cancer receiving first-line
chemotherapy. Acta Oncol 2021;60:1317-24. DOI
59. Dutkowski P, Oberkofler CE, Slankamenac K, et al. Are there better guidelines for allocation in liver transplantation? Ann Surg
2011;254:745-53; discussion 753. DOI
60. Nalesnik MA, Woodle ES, Dimaio JM, et al. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am
J Transplant 2011;11:1140-7. DOI
61. Ekser B, Li P, Cooper DKC. Xenotransplantation: past, present, and future. Curr Opin Organ Transplant 2017;22:513-21. DOI
PubMed PMC
62. Northup PG, Intagliata NM, Shah NL, Pelletier SJ, Berg CL, Argo CK. Excess mortality on the liver transplant waiting list: unintended
policy consequences and model for end-stage liver disease (MELD) inflation. Hepatology 2015;61:285-91. DOI PubMed